Exagen (XGN) Cash from Operations (2018 - 2026)

Exagen has reported Cash from Operations for 9 years, with the latest figure at 10417000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 2.38% year-over-year to 10417000.0; the trailing twelve-month figure through Mar 2026 stood at 13371000.0 (up 10.32% YoY), and the FY2025 full-year result was 13625000.0, down 2.61% from the prior year.
• Cash from Operations for Q1 2026 stood at 10417000.0, down from 3013000.0 in the prior quarter.
• The five-year high for Cash from Operations was 8349000.0 in Q4 2023, with the low at 11154000.0 in Q2 2022.
• Historically, Cash from Operations has averaged 4936882.35 across 5 years, with a median of 5734000.0 in 2022.
• Annual changes were most pronounced in 2023 — Cash from Operations soared 245.61% — and 2025, when it tumbled 930.03%.
• Exagen's Cash from Operations stood at 5734000.0 in 2022, then soared by 245.61% to 8349000.0 in 2023, then sank by 95.65% to 363000.0 in 2024, then plunged by 930.03% to 3013000.0 in 2025, then plunged by 245.74% to 10417000.0 in 2026.
• The last three Cash from Operations figures came in at 10417000.0 (Q1 2026), 3013000.0 (Q4 2025), and 2944000.0 (Q3 2025), per Business Quant data.